Shockwave Medical (NASDAQ:SWAV) Earns Equal Weight Rating from Morgan Stanley

Morgan Stanley reissued their equal weight rating on shares of Shockwave Medical (NASDAQ:SWAV – Free Report) in a research note published on Monday, Benzinga reports. The brokerage currently has a $335.00 price objective on the stock, up from their prior price objective of $285.00. A number of other equities research analysts also recently issued reports […]

Related Keywords

United States ,Trinh Phung ,Douglas Evan Godshall ,Piper Sandler ,Needham Company ,Lindbrook Capital ,Securities Exchange Commission ,Shockwave Medical Inc ,Wolfe Research ,Penderfund Capital Management Ltd ,Morgan Stanley ,Shockwave Medical Company Profile ,Rise Advisors ,Canaccord Genuity Group ,Eversource Wealth Advisors ,Shockwave Medical ,Free Report ,Genuity Group ,Get Free Report ,Exchange Commission ,Evan Godshall ,Source Wealth Advisors ,Penderfund Capital Management ,Shockwave Medical Daily ,Nasdaq Swav ,Swav ,Medical ,Reiterated Rating ,